Compound Detail
CHEMBL2079587
STANOZOLOL 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O
Basic Information
| ChEMBL ID | CHEMBL2079587 |
| Name | STANOZOLOL |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LKAJKIOFIWVMDJ-IYRCEVNGSA-N |
| Therapeutic | ✓ Yes |
7
Targets
11
Activities
2
Assay Types
0
PK Parameters
17
Publications
13
Known Names
1
Indications
1
Mechanisms
Molecular Properties
328.5
MW (Da)
4.12
ALogP
2
HBA
2
HBD
48.9
PSA (Ų)
0.75
QED
0
Ro5 Violations
0
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1962 |
| Availability | Discontinued |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Androgen Receptor agonist | AGONIST | Androgen receptor | ✓ | ✓ |
Indications
Myelodysplastic Syndromes
ATC Classification
A14AA02
stanozolol
Level 1: ALIMENTARY TRACT AND METABOLISM
Level 2: ANABOLIC AGENTS FOR SYSTEMIC USE
Activity Summary
IC50 7 meas. best 7.66
Ki 4 meas. best 7.82
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Androgen receptor CHEMBL3072 | Ki | 7.82 | 7.82 | 15.0 | 1 |
| Androgen receptor CHEMBL3072 | IC50 | 7.66 | 7.66 | 22.0 | 1 |
| Estrogen receptor CHEMBL206 | Ki | 7.5 | 7.5 | 32.0 | 1 |
| Cytochrome P450 2C19 CHEMBL3622 | IC50 | 7.32 | 7.32 | 48.0 | 1 |
| Estrogen receptor CHEMBL206 | IC50 | 6.95 | 6.95 | 113.0 | 1 |
| Progesterone receptor CHEMBL1909044 | Ki | 6.32 | 6.32 | 483.0 | 1 |
| Cytochrome P450 2C9 CHEMBL3397 | IC50 | 5.95 | 5.95 | 1127.6 | 1 |
| Progesterone receptor CHEMBL1909044 | IC50 | 5.43 | 5.43 | 3705.0 | 1 |
| Adenosine receptor A3 CHEMBL256 | Ki | 5.33 | 5.33 | 4705.0 | 1 |
| Adenosine receptor A3 CHEMBL256 | IC50 | 5.08 | 5.08 | 8325.0 | 1 |
| Cytochrome P450 2D6 CHEMBL289 | IC50 | 5.03 | 5.03 | 9274.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 408 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 20014752 | 10.1021/tx900326k | Hepatotoxicity | 3 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 38318365 | 10.1016/j.isci.2024.108907 | Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 | 1 |
| - | 10.6019/CHEMBL4513141 | Staphylococcus aureus | 1 |
| - | 10.6019/CHEMBL4513141 | Acinetobacter baumannii | 1 |
| - | 10.6019/CHEMBL4513141 | Pseudomonas aeruginosa | 1 |
| - | 10.6019/CHEMBL4513141 | Klebsiella pneumoniae | 1 |
| - | 10.6019/CHEMBL4513141 | Escherichia coli | 1 |
| - | 10.6019/CHEMBL4513141 | Cryptococcus neoformans | 1 |
| - | 10.6019/CHEMBL4513141 | Candida albicans | 1 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 1 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| - | 10.1101/2020.04.03.023846 | SARS-CoV-2 | 1 |
Data from ChEMBL 36 via Core Engine